The Supreme Court decision over Baraclude established a ground for the patent acceptance of usage and volume

The hepatitis type B treatment ‘Baraclude’ patent suit, won by Jeil Pharm on the last 21^st, has attracted interests of the pharmaceutical industry as founding a ground for pharmaceutical products to be accepted in usage and volume patents.

Based on the decision, multinational pharmaceutical companies owning new drugs is now able to gain more time from attacks of follow-up generics as taking ad...